---
$id: https://graph.org.ai/products/commodity/51282923
$type: Product
source: UNSPSC
code: "51282923"
title: "Grepafloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Grepafloxacin

**UNSPSC Code**: 51282923
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C19H22FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L1M1U2HC31, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo- but generally known as grepafloxacin, which bears US NIH Compound Identifier 72474. European Medicines Agency schedules Grepafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07965MIG. The term GREPAFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules grepafloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule grepafloxacin under HS 29335995 and SITC 51576. As of Q4 2014, GREPAFLOXACIN remains the US FDA Preferred Term for this commodity. Grepafloxacin bears US NLM identifiers UMLS ID C0287721 and NCI Concept Code C65817. SMILES: FC1C(N2CC(NCC2)C)CC2N(C3CC3)CC(C(=O)C2C1C)C(=O)O.

